Biogen
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Biogen's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 3% to $9,835,600,000. Profit margin reached 12%. Total operating expenses were $6,005,399,999.

Profit Margin

Biogen Inc. (NASDAQ:BIIB): Profit margin
2014 9.70B 2.93B 30.25%
2015 10.76B 3.54B 32.95%
2016 11.44B 3.70B 32.34%
2017 12.27B 2.53B 20.69%
2018 13.45B 4.43B 32.93%
2019 14.37B 5.88B 40.96%
2020 13.44B 4.00B 29.76%
2021 10.98B 1.55B 14.17%
2022 10.17B 3.04B 29.95%
2023 9.83B 1.16B 11.81%

BIIB Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
9.83B10.17B10.98B13.44B14.37B13.45B12.27B11.44B10.76B9.70B
Cost of revenue
2.53B2.27B2.10B1.80B1.95B1.81B1.63B1.47B1.24B1.17B
Gross profit
7.30B7.89B8.87B11.63B12.42B11.63B10.64B9.97B9.52B8.53B
Operating exp.
Research and development
2.46B2.23B2.50B3.99B2.28B2.59B2.25B1.97B2.01B1.89B
Selling and marketing
71.4M54.1M98.7M111.8M79.2M90.2M75.2M106.3M108.6M92.9M
Total operating expenses
6.00B4.99B6.06B7.19B5.38B5.63B5.11B4.31B4.50B4.61B
Operating income
2.09B2.32B2.84B4.55B7.04B5.88B5.34B5.15B4.89B3.97B
Other income (expenses), net
-800.5M1.27B-1.09B497.4M83.3M-101.2M-217M-720.1M-123.7M-25.76M
Income before tax
1.29B3.59B1.74B5.04B7.12B5.89B5.12B4.93B4.76B3.94B
Income tax expense
135.3M632.8M52.5M992.3M1.15B1.42B2.45B1.23B1.16B989.94M
Net income
1.16B3.04B1.55B4.00B5.88B4.43B2.53B3.70B3.54B2.93B
Earnings per share
Basic EPS
8.0220.9710.4424.8631.4721.6211.9416.9615.3812.42
Diluted EPS
7.9720.8710.424.831.4221.5811.9216.9315.3412.37
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source